Treatment of Malignant Pleural Mesothelioma: American Society of Clinical Oncology Clinical Practice Guideline.
Treatment of Malignant Pleural Mesothelioma: American Society of Clinical Oncology Clinical Practice Guideline.
复制标题
DOI：
10.1200/jco.2017.76.6394
复制
发表时间：
2018-05-01
期刊：
影响因子：
--
通讯作者：
Hassan R
中科院分区：
文献类型：
--
作者：
Kindler HL;Ismaila N;Armato SG 3rd;Bueno R;Hesdorffer M;Jahan T;Jones CM;Miettinen M;Pass H;Rimner A;Rusch V;Sterman D;Thomas A;Hassan R
为执业医师和其他人提供有关恶性胸膜间皮瘤治疗的循证建议。 ASCO 召集了一个由肿瘤内科、胸外科、放射肿瘤学、肺科、病理学、影像学和宣传专家组成的专家小组进行文献检索，其中包括 1990 年至 2017 年发表的系统评价、荟萃分析、随机对照试验以及前瞻性和回顾性比较观察研究。感兴趣的结果包括生存、无病或无复发生存以及生活质量。专家小组成员利用现有证据和非正式共识来制定基于证据的指南建议。文献检索确定了 222 项相关研究，为本指南提供证据基础。针对恶性胸膜间皮瘤患者的诊断、分期、化疗、细胞减灭术、放射治疗和多学科治疗制定了基于证据的建议。
To provide evidence-based recommendations to practicing physicians and others on the management of malignant pleural mesothelioma. ASCO convened an Expert Panel of medical oncology, thoracic surgery, radiation oncology, pulmonary, pathology, imaging, and advocacy experts to conduct a literature search, which included systematic reviews, meta-analyses, randomized controlled trials, and prospective and retrospective comparative observational studies published from 1990 through 2017. Outcomes of interest included survival, disease-free or recurrence-free survival, and quality of life. Expert Panel members used available evidence and informal consensus to develop evidence-based guideline recommendations. The literature search identified 222 relevant studies to inform the evidence base for this guideline. Evidence-based recommendations were developed for diagnosis, staging, chemotherapy, surgical cytoreduction, radiation therapy, and multimodality therapy in patients with malignant pleural mesothelioma.